- NOK4.22bn
- NOK4.06bn
- NOK699.77m
Brief: Medistim launches its new product MiraQ in US
Brief: MediStim submittes 510K application to the FDA for the new imaging product VeriQC
Brief: Blue Cap unit em-tec and Medistim to start international cooperation
Brief: Medistim Q3 EBIT up at NOK 12.7 million
Brief: Medistim enters into a strategic partnership with emtec GmbH
Brief: Medistim introduces new specialized product for vascular surgery
Brief: Medistim Q2 EBIT flat at NOK 11.7 million
Brief: Medistim strengthens its US operations and expands the sales force
Brief: Medistim introduced MiraQ Cardiac to Asian market in May
Brief: Medistim Q1 EBIT increases to NOK 9.9 mln
Brief: Medistim: Annulment of merger for Medistim second largest shareholder
Brief: Medistim Transfers 15,000 shares to CEO Kari Krogstad
Brief: Medistim Q4 EBIT increases to NOK 14.5 million
Brief: Medistim receives clearance for sale of VeriQ C in China
Brief: Medistims subsidiary Medistim Norge AS has won nationwide tender for breast implants
Brief: Medistim Q3 EBIT up 54.1 pct to NOK 10.0 mln
Brief: Medistim launches its new product MiraQ Cardiac at EACTS